Home›Companies›Biotech & Pharma›Deep Blue Medical Advances

Deep Blue Medical Advances, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 22, 2025·Suggest an edit

About Deep Blue Medical Advances

Deep Blue Medical Advances is a private company based in Durham, North Carolina. It has reported $18,124,913 raised in six offerings on Form D since January 2018. Its chief executive is William Perry.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 9, 2025Sep 22, 2025$5,261,533of $5.6M target105$50,110Equity, OptionsRule 506(b)Form D ↗
Jun 21, 2022Jun 30, 2022$7,033,711of $7.5M target113$62,245EquityRule 506(b)Form D ↗
Jun 27, 2019Feb 3, 2021$3,443,506of $3.5M target106$32,486EquityRule 506(b)Form D ↗
Dec 9, 2020Jan 28, 2021$1,574,163of $1.6M target73$21,564Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 5, 2018Aug 30, 2018$295,000fully sold18$16,389Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Dec 8, 2017Jan 24, 2018$517,000of $800K target18$28,722Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, six offerings$18,124,913

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Deep Blue Medical Advances's Form D filed Sep 22, 2025.

HL
Howard Levinson
Executive officer and director
WP
William Perry
CEO and director
MB
NM
Neil Meyer
Director
BD
Brent Duncan
Director

Earlier filings also listed Kenneth Gall (director, last listed Jun 2022), Robert Isaacs (director, last listed Aug 2018) and Robert Bonczek (director, last listed Aug 2018).

Sources

  1. SECDeep Blue Medical Advances, Inc. filing history